Alzheon Funding & Investors
Framingham, MA
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders.
https://alzheon.com/Total Amount Raised: $257,204,768
Alzheon Funding Rounds
Series E
$100,000,000
Series E Investors
Alerce Medical Technology PartnersSeries Unknown
$17,249,891
Series Unknown
$1,703,768
Series D
$50,000,000
Series Unknown
$2,432,016
Grant
$47,000,000
Grant Investors
NIASeries B
$15,764,099
Series B Investors
Ally Bridge GroupDebt Financing
$3,100,000
Debt Financing
$6,905,000
Series A
$10,000,000
Series A Investors
Ally Bridge GroupScott CohenSeries Unknown
$3,050,000
Funding info provided by Diffbot.